| Literature DB >> 31870285 |
Kevin Schneider1, Colin E Adams1,2, Kathryn R Elmer3.
Abstract
BACKGROUND: Salmonid fishes are characterised by a very high level of variation in trophic, ecological, physiological, and life history adaptations. Some salmonid taxa show exceptional potential for fast, within-lake diversification into morphologically and ecologically distinct variants, often in parallel; these are the lake-resident charr and whitefish (several species in the genera Salvelinus and Coregonus). To identify selection on genes and gene categories associated with such predictable diversifications, we analysed 2702 orthogroups (4.82 Mbp total; average 4.77 genes/orthogroup; average 1783 bp/orthogroup). We did so in two charr and two whitefish species and compared to five other salmonid lineages, which do not evolve in such ecologically predictable ways, and one non-salmonid outgroup.Entities:
Keywords: Adaptation; Diversification; Freshwater fishes; Gene ontology; Molecular evolution; Positive selection; Purifying selection; Relaxed selection; Selective pressure; Transcriptomics
Mesh:
Year: 2019 PMID: 31870285 PMCID: PMC6929470 DOI: 10.1186/s12864-019-6361-2
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Maximum-likelihood phylogenetic tree of nine salmonid species (foreground taxa Coregonus and Salvelinus in red) and outgroup northern pike (Esox lucius; in blue). Node support values are bootstrap values from 1000 bootstrap replications. Branch lengths correspond to the number of substitutions per site. All pictures used here are under public domain. Coregonus and Salvelinus are two genera with exceptional ability for repeated, rapid diversification into ecomorphs within lakes that is unmatched in other salmonid taxa [2, 43–47]
Fig. 2Histogram of the distribution of selection parameter k values (exponent of dN/dS ratio, i.e., k in ω) from RELAX analysis in the 2702 orthogroups. The values shown are for Coregonus and Salvelinus compared to the other five salmonid species and the outgroup (pike). The neutral expectation of k = 1 is shown as a vertical line. k values above 2 are omitted for visibility purposes in the above plot (416 orthogroups have k values above 2; the maximum possible k value is 50; see Additional file 1 for total set of k values)
Fig. 3Selection parameter k distributions for the gene ontology (GO) terms that deviated from the null expectation in the total set of 2702 orthogroups. k values are selection parameter values (exponent of dN/dS ratio, i.e., k in ω) in Coregonus and Salvelinus compared to the five other salmonid species and the outgroup (pike). The red horizontal bars indicate the medians of k
Fig. 4Gene Ontology (GO) terms with trends of overrepresentation (p < 0.05) in a the orthogroups under relaxed selection (FDR < 0.10), b the orthogroups under intensified selection (FDR < 0.10), and c the orthogroups under diversifying selection (FDR < 0.10). The orthogroups used are present in both Coregonus and Salvelinus. Bubble colour in the indicated colour spectrum corresponds to the log10 p-value of overrepresentation (blue = higher significance, red = lower significance). Bubble size corresponds to the frequency of a GO term in the orthogroups under selection. Highly similar GO terms are linked by edges in the graph, where the line width indicates the degree of similarity. The bubble placement corresponds to the position along two semantic space axes based on SimRel clustering as described in Material & methods [70]. Asterisks indicate overlap with enriched GO terms in orthogroups under other types of selection
Over- and underrepresented terms from a GO enrichment analysis. Cor = Coregonus, Salv = Salvelinus, OGs = orthogroups
| GO category | # in OGs under selection | # in reference OGs | # in OGs under selection (Cor + Salv) | # in reference OGs (Cor + Salv) | ||
|---|---|---|---|---|---|---|
| Overrepresented GO terms – relaxed selection | ||||||
| PTW/PP1 phosphatase complex | 2.55E-03 | 3.03E-03 | 2 | 0 | 2 | 0 |
| acrosome reaction | 2.55E-03 | 3.03E-03 | 2 | 0 | 2 | 0 |
| integral component of membrane | 3.96E-03 | 1.77E-02 | 21 | 205 | 17 | 163 |
| transcription factor complex | 4.59E-03 | 5.52E-02 | 11 | 78 | 8 | 68 |
| regulation of transcription, DNA-templated | 6.29E-03 | 3.12E-02 | 10 | 70 | 8 | 60 |
| DNA-binding transcription factor activity | 1.22E-02 | 5.98E-02 | 9 | 66 | 7 | 57 |
| regulation of transcription by RNA polymerase II | 1.35E-02 | 2.20E-01 | 4 | 15 | 2 | 14 |
| lipid metabolic process | 1.43E-02 | 8.76E-03 | 2 | 2 | 2 | 1 |
| protein serine/threonine kinase activity | 2.00E-02 | 1.48E-02 | 3 | 9 | 3 | 7 |
| protein tyrosine phosphatase activity | 2.30E-02 | 2.71E-02 | 2 | 3 | 2 | 3 |
| phospholipid catabolic process | 2.30E-02 | 2.71E-02 | 2 | 3 | 2 | 3 |
| tyrosine metabolic process | 3.34E-02 | 3.92E-02 | 2 | 4 | 2 | 4 |
| oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3.34E-02 | 2.71E-02 | 2 | 4 | 2 | 3 |
| serine family amino acid metabolic process | 3.70E-02 | 1.96E-02 | 3 | 12 | 3 | 8 |
| nucleus | 4.42E-02 | 6.75E-02 | 10 | 98 | 9 | 84 |
| Overrepresented GO terms – intensified selection | ||||||
| protein deubiquitination | 1.73E-03 | 1.33E-01 | 3 | 4 | 1 | 3 |
| regulation of transcription, DNA-templated | 2.17E-03 | 5.18E-03 | 10 | 81 | 8 | 70 |
| thiol-dependent ubiquitinyl hydrolase activity | 8.36E-03 | 1.02E-01 | 2 | 2 | 1 | 2 |
| DNA binding | 2.48E-02 | 1.68E-02 | 8 | 85 | 7 | 70 |
| steroid hormone receptor activity | 2.71E-02 | 2.29E-02 | 2 | 5 | 2 | 5 |
| acetyl-CoA carboxylase activity | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| acetyl-CoA carboxylase complex | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| Lys48-specific deubiquitinase activity | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| Sin3 complex | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| histone H3-K4 demethylation | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| retinoic acid biosynthetic process | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| NADP-retinol dehydrogenase activity | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| catalase activity | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| obsolete peroxidase reaction | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| response to oxidative stress | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| methane metabolic process | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| hydrogen peroxide catabolic process | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| palmitoyltransferase activity | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| beta1-adrenergic receptor activity | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| positive regulation of heart contraction | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| adrenergic receptor signaling pathway | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| adrenal gland development | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| corticotropin-releasing hormone binding | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| apoptotic signaling pathway | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| regulation of NIK/NF-kappaB signaling | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| iron-sulfur cluster binding | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| actin filament severing | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| dystrophin-associated glycoprotein complex | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| hexosaminidase activity | 3.85E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| hyaluronic acid binding | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| ribosomal large subunit biogenesis | 3.85E-02 | 3.52E-02 | 1 | 0 | 1 | 0 |
| Overrepresented GO terms – diversifying selection | ||||||
| transmembrane transporter activity | 2.28E-02 | 1.19E-02 | 4 | 23 | 4 | 18 |
| transmembrane transport | 2.17E-02 | 1.25E-02 | 6 | 48 | 6 | 41 |
| phospholipid metabolic process | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| regulation of Wnt signaling pathway | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| lipid phosphatase activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| proteolysis | 3.20E-02 | 2.18E-02 | 6 | 53 | 6 | 47 |
| acetyl-CoA carboxylase activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| pyruvate metabolic process | 1.67E-03 | 1.75E-03 | 2 | 0 | 2 | 0 |
| acetyl-CoA carboxylase complex | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| NAD-dependent histone deacetylase activity (H3-K14 specific) | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| histone H3 deacetylation | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| intracellular signal transduction | 1.51E-02 | 4.27E-02 | 4 | 20 | 3 | 16 |
| transforming growth factor beta receptor signaling pathway | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| serine-type endopeptidase activity | 5.27E-03 | 4.56E-03 | 4 | 14 | 4 | 13 |
| cytoskeleton | 4.98E-02 | 4.14E-02 | 2 | 7 | 2 | 6 |
| septin complex | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| complement activation | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| nociceptin receptor activity | 4.11E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| calcium-mediated signaling | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| glycerolipid metabolic process | 3.98E-02 | 4.14E-02 | 2 | 6 | 2 | 6 |
| kinesin complex | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| kinesin binding | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| lipid catabolic process | 4.88E-03 | 5.10E-03 | 2 | 1 | 2 | 1 |
| oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.25E-02 | 1.93E-01 | 2 | 4 | 1 | 4 |
| L-ascorbic acid binding | 1.54E-02 | 1.58E-01 | 2 | 3 | 1 | 3 |
| lipoprotein lipase activity | 1.67E-03 | 1.75E-03 | 2 | 0 | 2 | 0 |
| Lys48-specific deubiquitinase activity | 4.11E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| synapse | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| Sin3 complex | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| sulfate assimilation | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| adenylylsulfate kinase activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| sulfate adenylyltransferase (ATP) activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| glycogen metabolic process | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| antigen processing and presentation of endogenous peptide antigen via MHC class I | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| melatonin receptor activity | 4.11E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| 3-hydroxyisobutyrate dehydrogenase activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| NAD binding | 1.54E-02 | 1.61E-02 | 2 | 3 | 2 | 3 |
| urea transmembrane transporter activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| urea transmembrane transport | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| 5-methylcytosine catabolic process | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| methylcytosine dioxygenase activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| DNA demethylation | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| pyrroline-5-carboxylate reductase activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| proline biosynthetic process | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| malate dehydrogenase (decarboxylating) (NAD+) activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| malate metabolic process | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| proteasome regulatory particle assembly | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| beta1-adrenergic receptor activity | 4.11E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | 4.11E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| positive regulation of heart contraction | 4.11E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| adrenergic receptor signaling pathway | 4.11E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| small ribosomal subunit | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| 10-formyltetrahydrofolate catabolic process | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| formyltetrahydrofolate dehydrogenase activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| hydroxymethyl-, formyl- and related transferase activity | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| regulation of neuroinflammatory response | 4.11E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| hexosaminidase activity | 4.11E-02 | 1.00E+ 00 | 1 | 0 | 0 | 0 |
| junctional membrane complex | 4.11E-02 | 4.20E-02 | 1 | 0 | 1 | 0 |
| Underrepresented GO terms – diversifying selection | ||||||
| DNA binding | 1.89E-02 | 3.46E-02 | 0 | 93 | 0 | 77 |
Fig. 5Top ten enriched a biological process GO terms and b KEGG pathways based on a gene set enrichment analysis (GSEA) of all orthogroups in Coregonus and Salvelinus relative to non-diversifying taxa. Terms with negative scores (yellow) were inferred to be under relaxed selection and with positive scores (blue) under intensified selection. The normalised enrichment score is calculated from transformed k values of each gene in a gene set. ** indicates significant gene set enrichment after multiple correction (FDR < 0.2); * indicates significant gene set enrichment without multiple correction ( 0.05)
Fig. 6Overlapping orthogroups under selection and biological process GO terms. a Overlap between orthogroups under relaxed and diversifying or intensified and diversifying selection in both Coregonus and Salvelinus. b Biological process GO terms of orthogroups under both relaxed and diversifying selection. c Biological process GO terms of orthogroups under both intensified and diversifying selection. In b and c, rectangles are clustered into larger, coloured rectangles based on relationships among GO terms [70]
Orthogroups (OGs) with signals of relaxed and diversifying selection or intensified and diversifying selection. k values are selection parameter values (exponent of dN/dS ratio, i.e., k in ω). FDR values are from Benjamini-Hochberg FDR correction. Orthogroups shown are present in both Coregonus and Salvelinus. For aBSREL, p-values after correction for multiple testing (FDR < 0.10) are shown
| OG ID | Gene description | GO terms (obtained with Blast2GO) | Additional information (manually derived from UniProt/Swiss-Prot) | FDR (RELAX) | ||
|---|---|---|---|---|---|---|
| Relaxed & diversifying selection | ||||||
| OG0001544 | adaptor-related protein complex 1, mu 2 subunit (ap1m2) | intracellular protein transport; vesicle-mediated transport; clathrin adaptor complex | antigen processing and presentation of exogenous peptide antigen via MHC class II, regulation of defence response to virus by virus | 0.000 | 1.019E-05 | 0.04471 |
| OG0002461 | protein kinase C epsilon type-like (LOC106589411) | protein serine/threonine kinase activity; ATP binding; protein phosphorylation; serine family amino acid metabolic process; intracellular signal transduction | cell adhesion, motility, and cell cycle, neuron growth, ion channel regulation, immune response, signal transduction | 6.825E-08 | 6.478E-06 | 0.07476 |
| OG0003986 | solute carrier family 6 (neurotransmitter transporter), member 8 (slc6a8) | neurotransmitter:sodium symporter activity; cation transport; neurotransmitter transport; integral component of membrane | muscle contraction, required for the uptake of creatine in muscles and brain | 7.970E-05 | 3.046E-12 | 0.05603 |
| OG0000840 | probable histone deacetylase 1-B (hda1b) | nucleus; NAD-dependent histone deacetylase activity (H3-K14 specific); metal ion binding;histone H3 deacetylation | transcriptional regulation, cell cycle progression, developmental events | 0.0002432 | 1.952E-06 | 2.398E-12 |
| OG0005675 | E3 ubiquitin-protein ligase RNF128-like (LOC110537269), transcript variant X1 | – | interleukin regulation, T-cell control, functions in the patterning of the dorsal ectoderm, sensitises ectoderm to respond to neural-inducing signals | 0.0002432 | 1.282E-08 | 0.5357 |
| OG0004474 | endoplasmic reticulum aminopeptidase 1-like (LOC106570844) | endoplasmic reticulum membrane; proteolysis; regulation of blood pressure; zinc ion binding; antigen processing and presentation of endogenous peptide antigen via MHC class I; metalloaminopeptidase activity | regulation of innate immune response, response to bacterium, angiogenesis, regulation of blood pressure, fat cell differentiation | 0.01917 | 2.008E-05 | 0.1651 |
| OG0000651 | tyrosine-protein phosphatase non-receptor type 6-like (LOC106576571), transcript variant X3 | protein tyrosine phosphatase activity; protein dephosphorylation; tyrosine metabolic process | haematopoiesis, various immune functions | 0.03186 | 1.547E-06 | 0.3844 |
| OG0002139 | calcipressin-2-like (LOC109900784), transcript variant X1 | nucleic acid binding; calcium-mediated signaling | regulation of calcineurin-NFAT signalling cascade, calcium-mediated signalling, potential role in central nervous development | 0.06629 | 2.753E-11 | 0.6235 |
| OG0014882 | junctophilin-2 (LOC111976619) | junctional membrane complex | calcium ion homeostasis, regulation of cardiac muscle tissue development | 0.08725 | 3.460E-09 | 0.6595 |
| Intensified & diversifying selection | ||||||
| OG0000798 | acetyl-CoA carboxylase beta (acacb), transcript variant X3 | acetyl-CoA carboxylase activity; ATP binding; pyruvate metabolic process; fatty acid biosynthetic process; acetyl-CoA carboxylase complex; metal ion binding | regulation of cholesterol biosynthetic process, acetyl-CoA metabolic process | 0.000 | 0.000 | 4.683 |
| OG0011982 | synapsin-3 (LOC111950806) | ATP binding; neurotransmitter secretion; synaptic vesicle | neurotransmitter secretion, regulation of synaptic transmission, GABAergic | 0.0001606 | 0.000 | 8.330 |
| OG0004141 | clone Contig3164 cathepsin K precursor | proteolysis; cysteine-type peptidase activity | osteoclastic bone resorption, bone remodelling, collagen metabolic process | 0.0002432 | 3.664E-14 | 7.769 |
| OG0013215 | lysine-specific demethylase 4B-like (LOC106574093), transcript variant X3 | histone H3-K36 demethylation; histone H3-K9 demethylation (manually derived from UniProt/Swiss-Prot) | histone H3-K36 demethylation, histone H3-K9 demethylation, negative regulation of transcription | 0.003614 | 3.970E-12 | 10.28 |
| OG0003822 | sterile alpha motif domain-containing protein 9-like (LOC109881303), transcript variant X2 | protein binding | endosomal vesicle fusion | 0.006278 | 9.533E-06 | 1.603 |
| OG0007378 | alpha-2,8-sialyltransferase 8F-like (LOC106588277), transcript variant X2 | protein glycosylation; sialyltransferase activity | carbohydrate biosynthetic process, glycolipid metabolic process, ganglioside biosynthetic process, (modulation of cell signal transduction, maybe involved in function of nervous system) | 0.008768 | 2.090E-11 9.549E-08 | 1.9625 |
| OG0003820 | paired amphipathic helix protein Sin3a-like (LOC106587652), transcript variant X3 | transcription corepressor activity; transcription factor complex; negative regulation of transcription | negative regulation of transcription, regulation of lipid metabolic process, regulation of circadian rhythms | 0.01812 | 5.292E-09 | 1.450 |
| OG0004629 | furin-1-like (LOC106587394), transcript variant X2 | serine-type endopeptidase activity; proteolysis | involved in microbial infection, regulation of endopeptidase activity, TGF-beta-1 activation | 0.01896 | 0.000 | 19.99 |
| OG0010786 | serine/threonine-protein kinase 6 (stk6) | protein serine/threonine kinase activity; ATP binding; protein phosphorylation; serine family amino acid metabolic process | activation of protein kinase activity, regulation of transcription | 0.01972 | 0.000 | 6.183 |
| OG0012826 | beta-1,4-galactosyltransferase 6-like (LOC106560385), transcript variant X1 | carbohydrate metabolic process; transferase activity | neuronal maturation, axonal and myelin formation, lactosylceramide biosynthetic process, carbohydrate metabolic process | 0.03015 | 1.221E-12 | 6.768 |
| OG0010420 | torsin-1A-interacting protein 2 (LOC111975742) | endoplasmic reticulum organization; positive regulation of ATPase activity; protein localization to nuclear envelope (manually derived from UniProt/Swiss-Prot) | endoplasmic reticulum integrity, positive regulation of ATPase activity | 0.03800 | 0.000 | 1.870 |
| OG0011057 | receptor-interacting serine/threonine-protein kinase 4-like (LOC106567956) | protein kinase activity; protein binding; ATP binding; protein phosphorylation | positive regulation of NF-kappaB transcription factor activity | 0.08386 | 5.012E-06 | 3.356 |
Sources of transcriptome assemblies used in this study
| Transcriptomes | ||||
|---|---|---|---|---|
| PhyloFish ( | 158.5 | 66,996 | [ | |
| GATF00000000.1 (NCBI GenBank) | 188.7 | 55,424 | [ | |
| Salmon Transcriptome website ( | 209.2 | 130,599 | [ | |
| GSE59756 (NCBI Gene Expression Omnibus) | 159.8 | 183,740 | [ | |
| PhyloFish ( | 166.0 | 69,441 | [ | |
| PhyloFish ( | 160.9 | 67,157 | [ | |
| earlier version of GGAO00000000.1 (NCBI GenBank; made accessible upon request) | 59.0 | 44,348 | [ | |
| earlier version of GGAP00000000.1 (NCBI GenBank; made accessible upon request) | 59.5 | 44,354 | [ | |
| earlier version of GGAQ00000000.1 (NCBI GenBank; made accessible upon request) | 63.0 | 44,554 | [ | |
| earlier version of GGAR00000000.1 (NCBI GenBank; made accessible upon request) | 62.0 | 46,308 | [ | |
| Genome | ||||
| GCF_000233375.1 (NCBI RefSeq assembly) | 77.5 | 48,589 | [ | |